Henry Meds and Luma Health are both legitimate GLP-1 telehealth platforms offering compounded semaglutide and tirzepatide through a medication-focused, coaching-free clinical model. The medications are the same. The critical difference is pricing structure: Henry Meds uses dose-dependent tiered pricing that increases as patients escalate to maintenance doses, while Luma Health uses a flat rate — $197/month for semaglutide and $297/month for tirzepatide — across all dose tiers.
At starting doses, Henry Meds may appear cheaper. At therapeutic maintenance doses — where patients spend the majority of their 12 to 18-month treatment course — Luma Health is typically less expensive or equivalent, with the additional advantage of pricing certainty that Henry Meds' tiered model cannot offer.
Who Are Henry Meds and Luma Health?
Henry Meds is a well-established GLP-1 telehealth platform that has been operating since before the current wave of compounded GLP-1 providers entered the market. It focuses on a medication-only model — no app-based coaching, no behavioral modules, just clinical intake, prescribing, and compounded medication delivery. Henry Meds has built strong brand recognition, particularly among patients who discovered GLP-1 treatment through online communities, and it has operated at significant scale.
Luma Health is a focused GLP-1 telehealth provider offering compounded semaglutide and tirzepatide through the same medication-only model. Clinical services are provided by Wasef Health, PC. Medications are compounded by VialsRX, a licensed 503A sterile compounding pharmacy in Houston, TX (Texas State Board of Pharmacy license #35264, independently verifiable at pharmacy.texas.gov). Luma Health's distinguishing features are flat-rate pricing across all dose tiers, no contracts, and full pharmacy credential transparency.
For patients comparing these two providers specifically because they want a lean, clinical-only GLP-1 program without coaching overhead, the comparison comes down almost entirely to pricing, pharmacy transparency, and contract flexibility — since the clinical model and medication are functionally equivalent.
Henry Meds Pricing: What Patients Actually Pay
Henry Meds is one of the most frequently cited providers in the GLP-1 telehealth market for its advertised low starting prices. The entry-level pricing — often cited around $69 to $99 per month — has generated significant enrollment volume by appearing to offer dramatically low-cost access. Understanding how Henry Meds' pricing actually works over the course of a full treatment year is essential to evaluating the true comparison.
Henry Meds uses a dose-dependent pricing structure. The price at each dose tier reflects the medication cost at that concentration level. As patients follow the standard clinical titration schedule — starting at the lowest dose and escalating every four to eight weeks — the monthly cost increases at each tier. The advertised starting price applies only at the 0.25 mg weekly starting dose. By the time patients reach a therapeutic maintenance dose of 1.0 mg to 2.4 mg weekly (where most meaningful weight loss occurs), they are paying substantially more than the enrollment price.
Based on publicly available pricing as of June 2026, Henry Meds' semaglutide program pricing follows approximately this pattern:
| Semaglutide Dose | Treatment Phase | Henry Meds Est. Monthly | Luma Health Monthly |
|---|---|---|---|
| 0.25 mg/week | Starting dose (weeks 1–4) | ~$69–$99/mo | $197/mo |
| 0.5 mg/week | Titration (weeks 5–8) | ~$129–$169/mo | $197/mo |
| 1.0 mg/week | Mid-titration (weeks 9–16) | ~$199–$249/mo | $197/mo |
| 1.7 mg/week | Higher maintenance | ~$249–$299/mo | $197/mo |
| 2.4 mg/week | Full maintenance | ~$299–$349/mo | $197/mo |
| Est. 12-month total (with escalation) | ~$2,200–$3,600 | $2,364 (flat) | |
Henry Meds pricing estimates based on publicly available information as of June 2026. Actual prices vary by plan configuration. Annual total assumes standard titration: 2 months at starting dose, 2 months at mid-tier, 8 months at or near maintenance. Verify current pricing directly with Henry Meds before enrolling.
The critical insight from this table is that Luma Health's flat $197/month rate is actually lower than Henry Meds' pricing at every dose level above 0.5 mg weekly — and maintenance-dose patients spend eight to ten of their twelve treatment months at those higher tiers. Henry Meds' lower starting price is a real advantage for the first two to three months, but that advantage inverts at exactly the point when the medication is doing its most important clinical work.
True All-In Annual Cost Comparison
Five-Dimension Comparison: Beyond Price
Pricing Structure Luma Advantage
Henry Meds uses dose-dependent tiered pricing — the monthly cost increases as patients escalate to higher maintenance doses. Luma Health uses flat-rate pricing ($197/mo sema, $297/mo tirz) regardless of dose. Luma's flat rate is lower than Henry Meds at every dose tier above 0.5 mg weekly semaglutide. For patients who will spend the majority of treatment at maintenance doses — which is most patients — Luma's flat rate delivers both cost savings and price certainty.
Pharmacy Transparency Luma Advantage
Luma Health uses VialsRX, a 503A licensed sterile compounding pharmacy in Houston, TX (Texas State Board of Pharmacy license #35264, verifiable at pharmacy.texas.gov). Henry Meds does not consistently disclose their compounding pharmacy partners by name and license number on their consumer-facing website. For patients who want to independently verify the pharmacy preparing their injectable medication, this distinction is meaningful.
Clinical Model Equivalent
Both Henry Meds and Luma Health operate medication-only GLP-1 programs — no app-based coaching, no behavioral modules. Both conduct async telehealth intake reviews, issue prescriptions from US-licensed providers, and ship compounded medication directly to patients. Neither platform offers the in-app behavioral infrastructure that platforms like Found or Calibrate include. For patients who want a lean clinical model, both providers are equivalent in structure; the differences are in execution, price, and transparency.
Contract Terms Luma Advantage
Both platforms are typically month-to-month for standard plans. Luma Health is uniformly no-contract across all plan types — there are no commitment-period options. Henry Meds has offered promotional plans with commitment terms in the past; whether these exist at enrollment should be verified directly. The risk of commitment-period plans is financial exposure if you need to discontinue treatment early.
Brand Recognition Henry Meds Advantage
Henry Meds has been operating longer and has a larger established patient base, more patient reviews, and broader name recognition in GLP-1 telehealth communities. For patients who find comfort in choosing a well-known platform with a longer track record and more public patient experience data, Henry Meds' established presence is a genuine differentiator. Luma Health is a focused, transparent alternative but with a shorter publicly documented history.
Starting Price (First 2 Months) Henry Meds Advantage
At the lowest starting dose, Henry Meds' entry price of $69 to $99 per month is meaningfully lower than Luma Health's flat $197/month. For patients who want to start GLP-1 treatment at the lowest possible cost for the first one to two months before deciding whether to continue, Henry Meds' starting price offers a lower-cost entry point. The advantage inverts at higher doses — but for patients whose primary consideration is minimizing cost in the first phase, Henry Meds wins on month one and two pricing.
Who Each Provider Is Best For
The honest answer to "Henry Meds or Luma Health?" depends on your treatment timeline and your priority between lowest possible starting cost versus lowest predictable total annual cost.
Henry Meds is the better choice if your primary goal is minimizing the cost of the first one to three months of GLP-1 treatment — the starting dose phase — and you are uncertain whether you will continue beyond that initial period. Henry Meds' lower entry price ($69 to $99/month) means less financial commitment in the evaluation window. If you decide to continue long-term, you should revisit the comparison at that point, because Henry Meds becomes more expensive than Luma Health once you reach maintenance doses.
Luma Health is the better choice if you are committed to a 6 to 18-month treatment course and want the most cost-predictable, pharmacy-transparent, no-contract option. Luma's $197/month flat rate is lower than Henry Meds' pricing at every therapeutic maintenance dose — the doses where you will spend the majority of your treatment time and achieve the most meaningful outcomes. The flat-rate model also eliminates the common frustration of discovering mid-treatment that your monthly cost has increased at each dose escalation step.
Frequently Asked Questions
Is Henry Meds or Luma Health cheaper?
It depends on which phase of treatment you are comparing. At the starting dose (0.25 mg semaglutide weekly), Henry Meds is cheaper — approximately $69 to $99 per month versus Luma Health's $197/month. At therapeutic maintenance doses (1.0 mg to 2.4 mg weekly), Luma Health is cheaper — $197/month flat versus Henry Meds' $199 to $349/month. Since patients spend roughly two to three months at starting doses and eight to ten months at maintenance doses over a 12-month treatment course, Luma Health produces a lower total annual cost for patients who complete a full treatment year.
Are Henry Meds and Luma Health the same medication?
Both Henry Meds and Luma Health provide compounded semaglutide and tirzepatide prepared by licensed 503A sterile compounding pharmacies. The active pharmaceutical ingredient is the same in both cases — the same molecule, the same mechanism of action, the same expected clinical outcomes at equivalent doses. The differences between the two providers are in pricing, pharmacy transparency, and program structure — not in the pharmacology of the medication itself.
Does Henry Meds require a contract?
Henry Meds' standard plans are typically month-to-month without a contract commitment. However, Henry Meds has periodically offered promotional plans with commitment terms — often associated with introductory pricing discounts — that include minimum commitment periods. Whether a commitment plan is currently available and whether it applies to your enrollment should be verified directly with Henry Meds before completing enrollment. Luma Health is uniformly month-to-month across all plans with no contract options.
Why does Henry Meds charge different prices at different doses?
Henry Meds uses dose-dependent pricing because higher doses require more active pharmaceutical ingredient per vial, which costs more to compound. Rather than building an average across all dose tiers into a flat monthly rate, Henry Meds passes through the incremental cost of each dose tier to patients as a price increase at each escalation step. Luma Health's flat-rate model absorbs the variable cost of different dose tiers into a single monthly price — meaning higher-dose patients subsidize lower-dose patients slightly, but all patients get price certainty regardless of where they land on the dose spectrum.
How does Luma Health's pharmacy compare to Henry Meds'?
Luma Health uses VialsRX, a 503A licensed sterile compounding pharmacy in Houston, TX with a Texas State Board of Pharmacy license number (#35264) that is publicly verifiable at pharmacy.texas.gov. Henry Meds does not consistently disclose the name and license number of their compounding pharmacy partners on their consumer-facing website. Both providers use licensed 503A pharmacies, but only Luma Health makes the pharmacy identity independently verifiable without contacting customer support. For patients who want to verify pharmacy credentials before starting injectable medication, this difference is material.
Can I switch from Henry Meds to Luma Health without interrupting treatment?
Yes. The transition is clinically seamless because the active ingredient is the same and no washout period is required. The correct sequence is: enroll with Luma Health, wait for prescription approval and confirm a shipping timeline, then cancel Henry Meds before your next billing date. Your Luma Health provider prescribes at your current dose level — you do not restart titration. Use your remaining Henry Meds supply until the Luma Health medication arrives, then switch at your next scheduled injection day. For a detailed step-by-step guide, see our Henry Meds cancellation guide.
What is included in Luma Health's $197/month?
Luma Health's $197/month for semaglutide is fully all-inclusive: medication at all dose tiers throughout treatment, clinical provider review by Wasef Health, PC (including initial intake and ongoing dose management), free shipping to all 50 states via VialsRX, and no additional consultation, platform, or membership fees. The price does not change as your dose escalates. There are no contracts, no cancellation penalties, and no enrollment fees. The first invoice matches the advertised price exactly.
How do I choose between Henry Meds and Luma Health?
If you are starting GLP-1 treatment with genuine uncertainty about whether you will continue beyond the first two to three months — you want to test the medication before committing — Henry Meds' lower starting price offers a lower-cost evaluation window. If you are entering treatment with a 6 to 18-month commitment horizon and want the most cost-predictable, pharmacy-transparent, no-contract program at competitive maintenance-dose pricing, Luma Health is the stronger financial choice. The comparison is most clearly resolved by calculating what each provider costs at the maintenance dose you expect to reach — not the starting price — and comparing those numbers directly.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- Rubino DM, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- FDA. Wegovy (semaglutide) Prescribing Information. 2023. FDA.gov
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- Garvey WT, et al. AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3):1–203. Endocrine Practice